154 related articles for article (PubMed ID: 20934789)
21. Tamsulosin: alpha1-adrenoceptor subtype-selectivity and comparison with terazosin.
Muramatsu I; Taniguchi T; Okada K
Jpn J Pharmacol; 1998 Nov; 78(3):331-5. PubMed ID: 9869267
[TBL] [Abstract][Full Text] [Related]
22. The effects of tamsulosin, a high affinity antagonist at functional alpha 1A- and alpha 1D-adrenoceptor subtypes.
Noble AJ; Chess-Williams R; Couldwell C; Furukawa K; Uchyiuma T; Korstanje C; Chapple CR
Br J Pharmacol; 1997 Jan; 120(2):231-8. PubMed ID: 9117115
[TBL] [Abstract][Full Text] [Related]
23. Design and synthesis of novel alpha1a adrenoceptor-selective dihydropyridine antagonists for the treatment of benign prostatic hyperplasia.
Nagarathnam D; Wetzel JM; Miao SW; Marzabadi MR; Chiu G; Wong WC; Hong X; Fang J; Forray C; Branchek TA; Heydorn WE; Chang RS; Broten T; Schorn TW; Gluchowski C
J Med Chem; 1998 Dec; 41(26):5320-33. PubMed ID: 9857099
[TBL] [Abstract][Full Text] [Related]
24. Design, synthesis and biological evaluation of pyridine-phenylpiperazines: a novel series of potent and selective alpha1a-adrenergic receptor antagonist.
Kuo GH; Prouty C; Murray WV; Pulito V; Jolliffe L; Cheung P; Varga S; Evangelisto M; Shaw C
Bioorg Med Chem; 2000 Sep; 8(9):2263-75. PubMed ID: 11026539
[TBL] [Abstract][Full Text] [Related]
25. Role of the newer alpha, -adrenergic-receptor antagonists in the treatment of benign prostatic hyperplasia-related lower urinary tract symptoms.
Lowe FC
Clin Ther; 2004 Nov; 26(11):1701-13. PubMed ID: 15639685
[TBL] [Abstract][Full Text] [Related]
26. Tamsulosin potently and selectively antagonizes human recombinant α(1A/1D)-adrenoceptors: slow dissociation from the α(1A)-adrenoceptor may account for selectivity for α(1A)-adrenoceptor over α(1B)-adrenoceptor subtype.
Sato S; Hatanaka T; Yuyama H; Ukai M; Noguchi Y; Ohtake A; Taguchi K; Sasamata M; Miyata K
Biol Pharm Bull; 2012; 35(1):72-7. PubMed ID: 22223340
[TBL] [Abstract][Full Text] [Related]
27. Synthesis, structure-activity relationship and biological evaluation of novel arylpiperzines as α1A/1D-AR subselective antagonists for BPH.
Xu F; Chen H; Xu J; Liang X; He X; Shao B; Sun X; Li B; Deng X; Yuan M
Bioorg Med Chem; 2015 Dec; 23(24):7735-42. PubMed ID: 26643219
[TBL] [Abstract][Full Text] [Related]
28. Rational design, synthesis, biological evaluation, homology and docking studies of coumarin derivatives as α1 -adrenoceptor antagonists.
Zhou X; Chen YD; Wang T; Wang XB; Kong LY
Chem Biodivers; 2011 Jun; 8(6):1052-64. PubMed ID: 21674779
[TBL] [Abstract][Full Text] [Related]
29. Radioreceptor assay analysis of tamsulosin and terazosin pharmacokinetics.
Taguchi K; Schäfers RF; Michel MC
Br J Clin Pharmacol; 1998 Jan; 45(1):49-55. PubMed ID: 9489594
[TBL] [Abstract][Full Text] [Related]
30. Effects of tamsulosin metabolites at alpha-1 adrenoceptor subtypes.
Taguchi K; Saitoh M; Sato S; Asano M; Michel MC
J Pharmacol Exp Ther; 1997 Jan; 280(1):1-5. PubMed ID: 8996174
[TBL] [Abstract][Full Text] [Related]
31. The affinity and selectivity of α-adrenoceptor antagonists, antidepressants, and antipsychotics for the human α1A, α1B, and α1D-adrenoceptors.
Proudman RGW; Pupo AS; Baker JG
Pharmacol Res Perspect; 2020 Aug; 8(4):e00602. PubMed ID: 32608144
[TBL] [Abstract][Full Text] [Related]
32. High affinity ligands and potent antagonists for the α1D-adrenergic receptor. Novel 3,8-disubstituted [1]benzothieno[3,2-d]pyrimidine derivatives.
Romeo G; Salerno L; Pittalà V; Modica MN; Siracusa MA; Materia L; Buccioni M; Marucci G; Minneman KP
Eur J Med Chem; 2014 Aug; 83():419-32. PubMed ID: 24992070
[TBL] [Abstract][Full Text] [Related]
33. (Phenylpiperidinyl)cyclohexylsulfonamides: development of alpha1a/1d-selective adrenergic receptor antagonists for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms (BPH/LUTS).
Chiu G; Li S; Connolly PJ; Pulito V; Liu J; Middleton SA
Bioorg Med Chem Lett; 2007 Jul; 17(14):3930-4. PubMed ID: 17517507
[TBL] [Abstract][Full Text] [Related]
34. Design, Synthesis, and Biological Evaluation of Indoline and Indole Derivatives as Potent and Selective α1A-Adrenoceptor Antagonists.
Zhao F; Li J; Chen Y; Tian Y; Wu C; Xie Y; Zhou Y; Wang J; Xie X; Liu H
J Med Chem; 2016 Apr; 59(8):3826-39. PubMed ID: 27031406
[TBL] [Abstract][Full Text] [Related]
35. Effect of tamsulosin on spontaneous bladder contraction in conscious rats with bladder outlet obstruction: comparison with effect on intraurethral pressure.
Ohtake A; Ukai M; Saitoh C; Sonoda R; Noguchi Y; Okutsu H; Yuyama H; Sato S; Sasamata M; Miyata K
Eur J Pharmacol; 2006 Sep; 545(2-3):185-91. PubMed ID: 16887117
[TBL] [Abstract][Full Text] [Related]
36. Design, Synthesis, and Biological Evaluation of Novel Tetrahydroprotoberberine Derivatives (THPBs) as Selective α
Guo D; Li J; Lin H; Zhou Y; Chen Y; Zhao F; Sun H; Zhang D; Li H; Shoichet BK; Shan L; Zhang W; Xie X; Jiang H; Liu H
J Med Chem; 2016 Oct; 59(20):9489-9502. PubMed ID: 27709945
[TBL] [Abstract][Full Text] [Related]
37. Design, synthesis, and biological activity of prazosin-related antagonists. Role of the piperazine and furan units of prazosin on the selectivity for alpha1-adrenoreceptor subtypes.
Bolognesi ML; Budriesi R; Chiarini A; Poggesi E; Leonardi A; Melchiorre C
J Med Chem; 1998 Nov; 41(24):4844-53. PubMed ID: 9822553
[TBL] [Abstract][Full Text] [Related]
38. Identification of 3,4-dihydro-2H-thiochromene 1,1-dioxide derivatives with a phenoxyethylamine group as highly potent and selective α
Sakauchi N; Furukawa H; Shirai J; Sato A; Kuno H; Saikawa R; Yoshida M
Eur J Med Chem; 2017 Oct; 139():114-127. PubMed ID: 28800452
[TBL] [Abstract][Full Text] [Related]
39. The possible mechanism of hypotensive activity of some pyrrolidin-2-one derivatives with antagonist properties at alpha1-adrenoceptors.
Sapa J; Kubacka M
Eur J Pharmacol; 2011 Dec; 673(1-3):40-8. PubMed ID: 21605554
[TBL] [Abstract][Full Text] [Related]
40. α-Adrenoceptor antagonistic and hypotensive properties of novel arylpiperazine derivatives of pyrrolidin-2-one.
Zaręba P; Dudek M; Lustyk K; Siwek A; Starowicz G; Bednarski M; Nowiński L; Raźny K; Sapa J; Malawska B; Kulig K
Bioorg Med Chem; 2015 May; 23(9):2104-11. PubMed ID: 25813897
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
